New research published in the Journal of the American Medical Association (JAMA) provides compelling evidence that legal cannabis access may help address the ongoing opioid crisis.
Key Findings
The study analyzed data from 2010-2023 across all 50 states and found that states with medical cannabis programs saw a 20% reduction in opioid prescriptions and a 25% decrease in opioid-related overdose deaths.
Substitution Effect
Researchers identified a significant substitution effect, where patients with chronic pain conditions increasingly chose cannabis over opioid medications for pain management.
Implications for Policy
The findings add to growing evidence supporting cannabis as a harm reduction tool and may influence future policy decisions regarding medical marijuana programs.